Project Details
Description
A Two-Arm Randomized, Double-Blind, Placebo-Controlled Phase 2 Selection Trial to Evaluate the Efficacy and Safety of VB10.16 Alone or in Combination with Atezolizumab in Patients with HPV16-Positive, PD-L1-positive...
| Status | Active |
|---|---|
| Effective start/end date | 6/10/24 → 6/9/35 |
Funding
- NYKODE THERAPEUTICS ASA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.